S&P 500   2,978.61 (-0.65%)
DOW   26,815.44 (-0.78%)
QQQ   190.91 (-1.29%)
AAPL   234.93 (+0.25%)
FB   185.28 (-2.31%)
MSFT   136.78 (-1.93%)
GOOGL   1,240.62 (-1.06%)
AMZN   1,757.63 (-1.83%)
CGC   19.68 (-3.10%)
MU   43.43 (-4.42%)
GE   8.98 (-0.99%)
AMD   30.34 (-2.19%)
T   38.01 (+0.61%)
NFLX   274.23 (-6.52%)
S&P 500   2,978.61 (-0.65%)
DOW   26,815.44 (-0.78%)
QQQ   190.91 (-1.29%)
AAPL   234.93 (+0.25%)
FB   185.28 (-2.31%)
MSFT   136.78 (-1.93%)
GOOGL   1,240.62 (-1.06%)
AMZN   1,757.63 (-1.83%)
CGC   19.68 (-3.10%)
MU   43.43 (-4.42%)
GE   8.98 (-0.99%)
AMD   30.34 (-2.19%)
T   38.01 (+0.61%)
NFLX   274.23 (-6.52%)
Log in

Chemed Stock Price, News & Analysis (NYSE:CHE)

$416.02
-1.83 (-0.44 %)
(As of 10/18/2019 12:20 PM ET)
Today's Range
$416.02
Now: $416.02
$418.34
50-Day Range
$403.88
MA: $421.17
$439.82
52-Week Range
$260.03
Now: $416.02
$441.79
Volume673 shs
Average Volume110,979 shs
Market Capitalization$6.62 billion
P/E Ratio34.87
Dividend Yield0.31%
Beta1.11
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.78 billion
Cash Flow$15.06 per share
Book Value$36.93 per share

Profitability

Net Income$205.54 million

Miscellaneous

Employees15,707
Market Cap$6.62 billion
Next Earnings Date10/29/2019 (Confirmed)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.


Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, August 2nd. Investors of record on Monday, August 12th will be given a dividend of $0.32 per share on Tuesday, September 3rd. This represents a $1.28 annualized dividend and a yield of 0.31%. The ex-dividend date is Friday, August 9th. This is a boost from Chemed's previous quarterly dividend of $0.30. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed declared that its Board of Directors has initiated a stock repurchase program on Wednesday, March 7th 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Thursday, July, 25th. The company reported $3.36 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.09 by $0.27. The firm earned $473.60 million during the quarter, compared to analyst estimates of $471.72 million. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $2.81 EPS. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Chemed.

How can I listen to Chemed's earnings call?

Chemed will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY19 earnings guidance on Monday, August, 5th. The company provided earnings per share guidance of $13.65-13.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.22.

What price target have analysts set for CHE?

3 Wall Street analysts have issued 1 year price objectives for Chemed's shares. Their forecasts range from $405.00 to $500.00. On average, they expect Chemed's share price to reach $445.00 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View Analyst Price Targets for Chemed.

What is the consensus analysts' recommendation for Chemed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Has Chemed been receiving favorable news coverage?

News headlines about CHE stock have trended neutral on Friday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chemed earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Chemed.

Are investors shorting Chemed?

Chemed saw a decrease in short interest in September. As of September 30th, there was short interest totalling 265,800 shares, a decrease of 9.8% from the August 30th total of 294,600 shares. Based on an average daily trading volume, of 122,200 shares, the short-interest ratio is currently 2.2 days. Approximately 1.7% of the shares of the company are short sold. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), CVS Health (CVS), Walt Disney (DIS), Fortinet (FTNT), Micron Technology (MU), Vertex Pharmaceuticals (VRTX), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Celgene (CELG).

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.34%), Robeco Institutional Asset Management B.V. (0.27%), Envestnet Asset Management Inc. (0.21%), Nisa Investment Advisors LLC (0.07%), Decatur Capital Management Inc. (0.06%) and Assenagon Asset Management S.A. (0.05%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., TrimTabs Asset Management LLC, Hanson & Doremus Investment Management, Pacer Advisors Inc., Delta Capital Management LLC, Capital Insight Partners LLC and Crossmark Global Holdings Inc.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Decatur Capital Management Inc., Robeco Institutional Asset Management B.V., Nisa Investment Advisors LLC, Campbell & CO Investment Adviser LLC, State of Alaska Department of Revenue, Sabal Trust CO, Advisor Partners LLC and Envestnet Asset Management Inc.. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $416.26.

How big of a company is Chemed?

Chemed has a market capitalization of $6.63 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

What is Chemed's official website?

The official website for Chemed is http://www.chemed.com/.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  255 (Vote Outperform)
Underperform Votes:  330 (Vote Underperform)
Total Votes:  585
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel